Maheshwara Rao

Maheshwara Rao has a diverse and extensive work experience in the manufacturing and engineering industry. Maheshwara is currently serving as the Director of Manufacturing Operations at Calyxo, Inc. since January 2022. Prior to this role, they worked as a Senior Manager of Manufacturing Engineering at the same company from June 2020 to December 2021.

In 2020, Maheshwara worked as a Process Development Consultant at Nano Precision Medical from March to May.

From 2014 to 2020, they worked at NeoTract, where they held various positions. Maheshwara began as a Project Engineer Consultant from April to June 2014 and then became a Senior Manufacturing Engineer from July 2014 to February 2017. Maheshwara was then promoted to a Principal Engineer from March 2017 to February 2018. Maheshwara'sfinal role at NeoTract was as the Manager of Advanced Manufacturing Engineering from March 2018 to February 2020. In this role, they were responsible for leading the Advanced Manufacturing Engineering team and collaborating with the R&D department to optimize designs and implement Design for Manufacturing (DFM) principles into final components.

Prior to NeoTract, Maheshwara worked at Zosano Pharma from 2006 to 2013. Maheshwara started as an Associate Process Engineer from October 2006 to December 2008 and then became a Process Engineer III from December 2008 to June 2011. Maheshwara assumed the position of Senior Process Engineer from March 2011 to December 2013. At Zosano Pharma, they played a crucial role in scaling the manufacturing of a novel transdermal drug delivery system and gaining expertise in custom equipment procurement and development.

Before Zosano Pharma, they worked at Johnson & Johnson as a Process Engineer I/II from January 2005 to October 2006, and at ALZA Corporation as a Process Engineering Co-op from January 2004 to July 2004.

Maheshwara Rao has a Bachelor of Science degree in Mechanical Engineering from the University of California, Berkeley. The duration of their studies at this institution is not mentioned.